Peer-reviewedCC BYFrontiers in clinical diabetes and healthcare
Real-world safety profile of finerenone in patients with type 2 diabetes and chronic kidney disease: a multi-database pharmacovigilance analysis of the FAERS and JADER systems
- 1Department of Pharmacy, Yancheng First Hospital Affiliated Hospital of Nanjing University Medical School, The First People’s Hospital of Yancheng , , ,
- 2Oncology Department, Yancheng First Hospital Affiliated Hospital of Nanjing University Medical School, The First People’s Hospital of Yancheng , , ,
Related
- Safety Profile of Tirzepatide in Real‐World Clinical Practice: A Pharmacovigilance Study Using the FAERS Database
- The Real-World Safety Profile of Haloperidol: A Comprehensive Pharmacovigilance Analysis Using the Large-Scale FAERS Database.
- Safety signals of tocilizumab in pediatric patients: A real-world pharmacovigilance analysis based on the FAERS database with network pharmacology insights.
- Cardiovascular risk profile and treatment patterns in patients with type 2 diabetes in specialized cardiology outpatient care in Colombia : A retrospective cross-sectional study
- Combination finerenone and empagliflozin for chronic kidney disease with type 2 diabetes: a target trial emulation
BibTeX
@article{zhang2026realworld,
title = {{Real-world safety profile of finerenone in patients with type 2 diabetes and chronic kidney disease: a multi-database pharmacovigilance analysis of the FAERS and JADER systems}},
author = {Dan Zhang and Yun Zhao and Haiting Chen and Yang Miao},
journal = {Frontiers in clinical diabetes and healthcare},
year = {2026},
month = nov,
url = {https://europepmc.org/article/PMC/PMC13727449},
note = {CC BY},
}
RIS
TY - JOUR
TI - Real-world safety profile of finerenone in patients with type 2 diabetes and chronic kidney disease: a multi-database pharmacovigilance analysis of the FAERS and JADER systems
AU - Dan Zhang
AU - Yun Zhao
AU - Haiting Chen
AU - Yang Miao
PY - 2026
DA - 2026/11/04
JO - Frontiers in clinical diabetes and healthcare
UR - https://europepmc.org/article/PMC/PMC13727449
SN - 2673-6616
ER -